Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Intensity-Modulated Radiation Therapy · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Intensity-Modulated Radiation Therapy | PROCEDURE | - |
Inclusion Criteria: * Squamous cell cancer of head and neck for radical/postoperative radiation therapy * American Joint Committee on Cancer (AJCC) stage I-IV with M0 and N0-2 disease * Karnofsky performance status (KPS) \>= 70% Exclusion Criteria: * M1 or N3 disease * Ineligibility for radiother...
Top 20 of 58 competitors
Intensity-Modulated Radiation Therapy (IMRT) is used for the treatment of Head and Neck Cancer. It is a type of radiation therapy that is being studied in a Phase 1 clinical trial to permit sparing of parotid gland function, which may help reduce side effects in patients undergoing radiation treatment.
Intensity-Modulated Radiation Therapy is being developed by Avalon GloboCare Corp. (NASDAQ: ALBT). The company is conducting clinical research on this radiation therapy approach for the treatment of Head and Neck Cancer.
Intensity-Modulated Radiation Therapy is in Phase 1 clinical development for Head and Neck Cancer. It is an investigational therapy, meaning it is still being studied in clinical trials and has not yet been approved for general medical use.
Intensity-Modulated Radiation Therapy is being studied in one completed clinical trial, NCT00137475, titled "Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function." This Phase 1 trial enrolled 130 participants with Head and Neck Cancer in Canada.
Yes, Intensity-Modulated Radiation Therapy is commonly referred to as IMRT. It is a radiation therapy technique used in the treatment of Head and Neck Cancer, and it is being investigated in a Phase 1 clinical trial for its potential to spare parotid gland function.